Pharmacological interventions for recurrent abdominal pain in childhood

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 3, 2017, Pages

  Martin, Alice E ^a   Newlove Delgado, Tamsin V ^b   Abbott, Rebecca A ^b   Bethel, Alison ^b   Thompson Coon, Joanna ^b   Whear, Rebecca ^b   Logan, Stuart ^b  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HORMONE; MUSCARINIC RECEPTOR BLOCKING AGENT; SEROTONIN 4 AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ACADEMIC ACHIEVEMENT; CHILD; CHILDHOOD DISEASE; DISEASE DURATION; DRUG EFFICACY; HORMONAL THERAPY; HUMAN; PAIN INTENSITY; PHARMACEUTICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; SOCIAL STATUS; SYSTEMATIC REVIEW; ADOLESCENT; META ANALYSIS; PRESCHOOL CHILD; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TREATMENT OUTCOME;

EID: 85014521008     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010973.pub2     Document Type: Review

References (109)

1. Asgarshirazi M, Shariat M, Dalili H. Comparison of the effects of pH-dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo-controlled study. Iran Red Cresent Medical Journal 2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339]5290344
2. Bahar RJ, Collins BS, Steinmetz B, Ament ME. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. Journal of Pediatrics 2008;152(5):685-9. [DOI: 10.1016/j.jpeds.2007.10.012; PUBMED: 18410774]5290346
3. Collins BS, Lin HC. Double-blind, placebo-controlled antibiotics treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain. Journal of Pediatric Gastroenterology and Nutrition 2011;52(4):382-6. [DOI: 10.1097/MPG.0b013e3181effa3b; PUBMED: 21240023]5290348
4. Heyland K, Friedt M, Buehr P, Braegger CP. No advantage for antibiotic treatment over placebo in Blastocystis hominis-positive children with recurrent abdominal pain. Journal of Pediatric Gastroenterology and Nutrition 2012;54(5):677-9. [DOI: 10.1097/MPG.0b013e31823a29a7; PUBMED: 22002479]5290350
5. Karabulut GS, Beşer OF, Erginöz E, Kutlu T, Cokuğraş FÇ, Erkan T. The incidence of irritable bowel syndrome in children using the Rome III criteria and the effect of trimebutine treatment. Journal of Neurogastroenterology and Motility 2013;19(1):90-3. [DOI: 10.5056/jnm.2013.19.1.90; PMC3548133; PUBMED: 23350053]5290352
6. Karunanayake A, Devanarayana NM, Rajindrajith S, de Silva A. OP-7 Therapeutic effects of domperidone on abdominal pain-predominant functional gastrointestinal disorders: randomised, double-blind, placebo-controlled trial. Journal of Pediatric Gastroenterology and Nutrition 2015;61(4):511-2. [DOI: 10.1097/01.mpg.0000472211.46517.33; PUBMED: 26439548]5290354
7. Khoshoo V, Armstead C, Landry L. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2006;23(1):191-6. [DOI: 10.1111/j.1365-2036.2006.02705.x; PUBMED: 16393297]5290356
8. Kline RM, Kline JJ, Di Palma J, Barbero GJ. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. Journal of Pediatrics 2001;138(1):125-8. [PUBMED: 11148527]5290358
9. Narang M, Shah D, Akhtar H. Efficacy and safety of drotaverine hydrochloride in children with recurrent abdominal pain: a randomized placebo controlled trial. Indian Pediatrics 2015;52(10):847-51. [PUBMED: 26499007]5290360
10. Pourmoghaddas Z, Saneian H, Roohafza H, Gholamrezaei A. Mebeverine for pediatric functional abdominal pain: a randomized, placebo-controlled trial. BioMed Research International 2014;191026:Epub 2014 Jun 25. [DOI: 10.1155/2014/191026; PMC4095832; PUBMED: 25089264]5290362
11. Roohafza H, Pourmoghaddas Z, Saneian H, Gholamrezaei A. Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Neurogastroenterology & Motility 2014;26(11):1642-50. [DOI: 10.1111/nmo.12444]5290364
12. Sadeghian M, Farahmand F, Fallahi GH, Abbasi A. Cyproheptadine for the treatment of functional abdominal pain in childhood: a double-blinded randomized placebo-controlled trial. Minerva Pediatrica 2008;60(6):1367-74. [PUBMED: 18971897]5290366
13. Saps M, Youssef N, Miranda A, Nurko S, Hyman P, Cocjin J, et al. Multicenter, randomised, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology 2009;137(4):1261-9. [DOI: 10.1053/j.gastro.2009.06.060]5290368
14. See MC, Birnbaum AH, Schechter CB, Goldenberg MM, Benkov KJ. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment. Digestive Diseases and Sciences 2001;46(5):985-92. [PUBMED: 11341669]5290370
15. Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Archives of Disease in Childhood 1995;72(1):48-50. [PMC1510964; PUBMED: 7717738]5290372
16. Zybach K, Friesen CA, Schurman JV. Therapeutic effect of melatonin on pediatric functional dyspepsia: a pilot study. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016;7(1):156-61. [DOI: 10.4292/wjgpt.v7.i1.156; PMC4734949; PUBMED: 26855822]5290374
17. Christensen MF. Letter: Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Archives of Disease in Childhood 1995;73(2):183. [DOI: 10.1136/adc.73.2.183-a]5290376
18. Cucchiara S, Bortolotti M, Minella R, Manzi G, Vitiello G, Iervolino C, et al. Children with functional gastrointestinal symptoms: effects of cisapride on fasting antroduodenal motility, gastric emptying of liquids and symptoms. European Journal of Gastroenterology and Hepatology 1992;4(8):627-33. 5290378
19. Dehghani SM, Imanieh MH, Oboodi R, Haghighat M. The comparative study of the effectiveness of cimetidine, ranitidine, famotidine, and omeprazole in treatment of children with dyspepsia. ISRN Pediatrics 2011;219287:Epub 2011 Apr 5. [DOI: 10.5402/2011/219287; PMC3263570; PUBMED: 22389770]5290380
20. Di Nardo G, Barbara G, Oliva S, Cremon C, Aloi M, Mallardo S, et al. Efficacy and tolerability of alpha-galactosidase on gas related symptoms in pediatric irritable bowel syndrome. A randomized, double-blind, placebo controlled trial. Digestive and Liver Disease 2011;43(Suppl 5):S412. [DOI: 10.1016/S1590-8658(11)60645-2]5290382
21. Everitt HA, Moss-Morris RE, Sibelli A, Tapp L, Coleman N, Yardley LS, et al. Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial). BMC Gastroenterology 2010;10:136. [DOI: 10.1186/1471-230X-10-136; PMC2998449; PUBMED: 21087463]5290384
22. Grillage MG, Nankani JN, Atkinson SN, Prescott P. A randomised, double-blind study of mebeverine versus dicyclomine in the treatment of functional abdominal pain in young adults. British Journal of Clinical Practice 1990;44(5):176-9. [PUBMED: 2202405]5290386
23. Kaminski A, Kamper A, Thaler K, Chapman A, Gartlehner G. Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD008013]5290388
24. Lloyd-Still JD. Azathioprine and the treatment of chronic inflammatory bowel disease. Journal of Pediatrics 1990;117(5):732-5. [DOI: 10.1016/S0022-3476(05)83329-3]5290390
25. Van Outryve S, Van Outryve M, Pelckmans P. Tegaserod: the ultimate treatment for constipation-predominant IBS? [Tegaserod bij het obstipatie-predominante prikkelbaredarmsyndroom: de ultieme behandeling?]. Tijdschrift voor Geneeskunde 2005;61(16):1110-7. [DOI: 10.2143/TVG.61.16.5002245]5290392
26. Xiao M, Qiu X, Yue D, Cai Y, Mo Q. Influence of hippophae rhamnoides on two appetite factors, gastric emptying and metabolic parameters, in children with functional dyspepsia. Hellenic Journal of Nuclear Medicine 2013;16(1):38-43. [DOI: 10.1967/s002449910070; PUBMED: 23529392]5290394
27. Yadav SK, Jain AK, Tripathi SN, Gupta JP. Irritable bowel syndrome: therapeutic evaluation of indigenous drugs. Indian Journal of Medical Research 1989;90:496-503. [PUBMED: 2697693]5290396
28. Abbott R. Study information [personal communication]. Email to: B Collins 14 March 2014.
29. Abbott R. Study information [personal communication]. Email to: R Bahar 25 April 2014.
30. Abbott RA, Martin AE, Newlove-Delgado TV, Bethel A, Thompson-Coon J, Whear R, et al. Psychosocial interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD010971.pub2]
31. Abu-Arafeh I, Russell G. Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Archives of Disease in Childhood 1995;72(5):413-7. [PMC1511089; PUBMED: 7618907]
32. Anonymous . Adverse reactions to food additives. Journal of the Royal College of Physicians of London 1984;18(2):115-6.
33. Apley J, Naish N. Recurrent abdominal pains: a field survey of 1000 school children. Archives of Disease in Childhood 1958;33(168):165-70. [PMC2012205]
34. Apley J. The Child With Abdominal Pains. 2nd Edition. Oxford: Blackwell Scientific Publications, 1975.
35. Asgarshirazi M. Re: study information [personal communcation]. Email to: A Martin 1 November 2016.
36. Bain HW. Chronic vague abdominal pain in children. Pediatric Clinics of North America 1974;21(4):991-1001. [PUBMED: 4427792]
37. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6. [DOI: 10.1016/j.jclinepi.2010.07.015; PUBMED: 21208779]
38. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88. [PUBMED: 3802833]
39. Di Lorenzo C, Youssef NN, Sigurdsson L, Scharff L, Griffiths J, Wald A. Visceral hyperalgesia in children with functional abdominal pain. Journal of Pediatrics 2001;139(6):838-43. [DOI: 10.1067/mpd.2001.118883; PUBMED: 11743510]
40. Drossman DA, Creed FH, Fava GA, Olden KW, Patrick DL, Toner BB, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology International 1995;8(2):47-90.
41. Edwards MC, Mullins LL, Johnson J, Bernardy N. Survey of pediatricians' management practices for recurrent abdominal pain. Journal of Pediatric Psychology 1994;19(2):241-53. [PUBMED: 8051605]
42. Farquar HG. Abdominal migraine in children. British Medical Journal 1956;1(4975):1082-5. [PMC1979859]
43. Faull C, Nicol AR. Abdominal pain in six-year-olds: an epidemiological study in a new town. Journal of Child Psychology and Psychiatry and Allied Disciplines 1986;27(2):251-60. [3958079]
44. Goadsby PJ, Hargreaves RJ. Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan. Neurology 2000;55(9 Suppl 2):S8-14. [PUBMED: 11089513]
45. Good PA. Neurologic investigations of childhood abdominal migraine: a combined electrophysiologic approach to diagnosis. Journal of Pediatric Gastroenterology and Nutrition 1995;21(Suppl 1):S44-8. [PUBMED: 8708868]
46. Schünemann H, Brozek J, Guyatt G, Oxman A. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013. gdt.guidelinedevelopment.org/app/handbook/handbook.html (accessed 22 March 2016).
47. McMaster University. GRADEpro Guideline Development Tool. Developed by Evidence Prime, Inc., 2015.
48. Grigoleit HG, Grigoleit P. Peppermint oil in irritable bowel syndrome. Phytomedicine 2005;12(8):601-6. [DOI: 10.1016/j.phymed.2004.10.005; PUBMED: 16121521]
49. Harvey RF, Pomare EW, Heaton KW. Effects of increased dietary fibre on intestinal transit. Lancet 1973;301(7815):1278-80. [DOI: 10.1016/S0140-6736(73)91294-4]
50. Heldenberg D, Wagner Y, Heldenberg E, Keren S, Auslaender L, Kaufshtein M, et al. The role of Helicobacter pylori in children with recurrent abdominal pain. American Journal of Gastroenterology 1995;90(6):906-9.
51. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [DOI: 10.1136/bmj.327.7414.557]
52. Higgins JPT, Altman DG, Sterne JAC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
53. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
54. Deeks JJ, Higgins JPT, Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
55. Hills JM, Aaronson PI. The mechanism of action of peppermint oil on gastrointestinal smooth muscle. Gastroenterology 1991;101(1):55-65. [PUBMED: 1646142]
56. Hockaday JM. Is there a place for "abdominal migraine" as a separate entity in the IHS classification? No!. Cephalalgia 1992;12(6):346-8. [PUBMED: 1473134]
57. Huertas-Ceballos A, Macarthur C, Logan S. Psychosocial interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD003014.pub2]
58. Huertas-Ceballos A, Logan S, Bennett C, Macarthur C. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD003019.pub3]
59. Hyams JS, Treem WR, Justinich CJ, Davis P, Shoup M, Burke G. Characterization of symptoms in children with recurrent abdominal pain: resemblance to irritable bowel syndrome. Journal of Pediatric Gastroenterology and Nutrition 1995;20(2):209-14. [PUBMED: 7714688]
60. Hyams JS, Hyman PE. Recurrent abdominal pain and the biopsychosocial model of medical practice. Journal of Pediatrics 1998;133(4):473-8. [PUBMED: 9787683]
61. Kovacs M. The Children's Depression Inventory. Psychopharmacology Bulletin 1985;21(4):995-8. [PUBMED: 4089116]
62. Martin A. Tegasterod in IBS [personal communication]. Email to: V Khoshoo 16 August 2014.
63. Martin A. RAP paper in Gastroenterology [personal communication]. Email to: M Saps 6 August 2014.
64. Martin A. Domperidone in RAP [personal communication]. Email to: A de Silva 6 July 2016.
65. Martin A. Study information [personal communication]. Email to: C Friesen 29 June 2016.
66. Martin A. Antibiotics and RAP in children [personal communication]. Email to: C Braegger 7 December 2016.
67. Martin A. Domperidone in RAP [personal communication]. Email to: A de Silva 27 November 2016.
68. Martin A. Trimebutine + IBS [personal communication]. Email to: O Beser 7 December 2016.
69. Martin A. Peppermint oil paper for IBS [personal communication]. Email to: R Kline 7 December 2016.
70. Martin A. Study information [personal communication]. Email to: M Asgarshirazi 29 September 2016.
71. Mayer EA, Collins SM. Evolving pathophysiology models of functional gastrointestinal disorders. Gastroenterology 2002;122(7):2032-48. [PUBMED: 12055608]
72. Milla PJ. Irritable bowel syndrome in childhood. Gastroenterology 2001;120(1):287-90. [PUBMED: 11208737]
73. Newlove-Delgado T, Martin A, Abbott R, Bethel A, Thompson-Coon J, Whear R, et al. Pharmacological interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews (in press).
74. National Institute of Mental Health. Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacology Bulletin 1985;21(4):714-1124. [PUBMED: 3911249]
75. Painter NS, Truelove SC. Irritable bowel syndrome in childhood. Gut 1964;5:201.
76. Patrick DL, Drossman DA, Ihunnaya OF. A Quality of Life Measure for Persons With Irritable Bowel Syndrome (IBS-QOL). User's Manual and Scoring Diskette for United States version. Seattle: University of Washington, 1997.
77. Peltonen T. Recurrent abdominal pain. Pediatrics 1970;46(6):973.
78. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. American Journal of Gastroenterology 1998;93(7):1131-5. [DOI: 10.1111/j.1572-0241.1998.00343.x; PUBMED: 9672344]
79. Poley JR, Bhatia M. Recurrent abdominal pain: recurrent controversy. Pediatrics 1973;52(1):144-5. [PUBMED: 4724433]
80. Primelles D, Grass M, Campoy PE, Estrada R, Carvajal A, Rubino de la Rosa J. Recurrent abdominal pain in childhood: retrospective study of 150 cases [Dolor abdominal recurrente en la infancia: estudio retrospectivo de 150 casos]. Revista Cubana de Pediatria 1990;62(1):18-27.
81. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006;130(5):1527-37. [DOI: 10.1053/j.gastro.2005.08.063; PUBMED: 16678566]
82. Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, et al. Childhood functional gastrointestinal disorders. Gut 1999;45(Suppl II):II60-8. [DOI: 10.1136/gut.45.2008.ii60; PMC1766693]
83. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
84. Reynolds CR, Richmond BO. Factor structure and construct validity of "what I think and feel": the revised Children's Manifest Anxiety Scale. Journal of Personality Assessment 1979;43(3):281-3.
85. Rubin LS, Barbero GL, Sibinga MS. Pupillary reactivity in children with recurrent abdominal pain. Psychosomatic Medicine 1967;29(2):111-20. [PUBMED: 6030151]
86. Ruepert L, Quartero AO, De Wit NJ, Van Der Heijden GJ, Rubin G, Muris JWM. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD003460.pub3]
87. Sandberg DH. Additional references on the tension-fatigue syndrome. Pediatrics 1973;51(2):308-9. [PUBMED: 4572072]
88. Scharff L. Recurrent abdominal pain in children: a review of psychological factors and treatment. Clinical Psychology Review 1997;17(2):145-66. [PUBMED: 9140713]
89. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
90. Speer F. The allergic tension-fatigue syndrome. Pediatric Clinics of North America 1954;11:1029-37. [PUBMED: 13204094]
91. Stickler GB, Murphy DB. Recurrent abdominal pain. American Journal of Diseases in Children 1979;133(5):486-9. [PUBMED: 433872]
92. Stone RT, Barbero GJ. Recurrent abdominal pain in childhood. Pediatrics 1970;45(5):732-8.
93. Stowens D. Recurrent abdominal pain. Pediatrics 1970;46(6):968-9.
94. Størdal, K, Nygaard E, Bentsen B. Recurrent abdominal pain: a five-year follow-up study. Acta Paediatrica 2005;94(2):234-6. [PUBMED: 15981760]
95. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000;320(7249):1574-7. [DOI: 10.1136/bmj.320.7249.1574]
96. Svedulend J, Sjodin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Digestive Diseases and Sciences 1988;33(2):129-34. [PUBMED: 3123181]
97. Symon DN, Russell G. Abdominal migraine: a childhood syndrome defined. Cephalalgia 1986;6(4):223-8. [PUBMED: 3802189]
98. Van Ginkel R, Voskuijl WP, Benninga MA, Taminiau JA, Boeckxstaens GE. Alterations in rectal sensitivity and motility in childhood irritable bowel syndrome. Gastroenterology 2001;120(1):31-8. [PUBMED: 11208711]
99. Walker LS, Smith CA, Garber J, Van Slyke DA. Development and validation of the Pain Response Inventory for children. Psychological Assessment 1997;9(4):392-405.
100. Walker LS, Guite JW, Duke M, Barnard JA, Greene JW. Recurrent abdominal pain: a potential precursor of irritable bowel syndrome in adolescents and young adults. Journal of Pediatrics 1998;132(6):1010-5. [PUBMED: 9627595]
101. Walker LS, Beck JE, Garber J, Lambert W. Children's Somatization Inventory: psychometric properties of the revised form (CSI-24). Journal of Pediatric Psychology 2009;34(4):430-40.
102. Wardhan H, Ojha P, Kulshrestha R. Recurrent abdominal pain in children in developing countries frequently has an organic basis. Pediatric Surgery International 1993;8:20-2. [DOI: 10.1016/0022-3468(93)90195-Q]
103. Williams K, Chambers M, Logan S, Robinson D. Association of common health symptoms with bullying in primary school children. BMJ 1996;313(7048):17-9. [PMC2351438]
104. Worawattanakul M, Rhoads JM, Lichtman SN, Ulshen MH. Abdominal migraine: prophylactic treatment and follow up. Journal of Pediatric Gastroenterology and Nutrition 1999;28(1):37-40. [PUBMED: 9890466]
105. Zhang H, Luo LL, Wang Y, Sun M. Diagnosis and treatment for recurrent abdominal pain in infant. Sapparo Medical Journal 1991;60(6):561-3.
106. Øster J. Recurrent abdominal pain, headache and limb pains in children and adolescents. Pediatrics 1972;50(3):429-36. [PUBMED: 5056416]
107. Huertas-Ceballos A, Macarthur C, Logan S. Pharmacological interventions for recurrent abdominal pain (RAP) in childhood. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD003017]
108. Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD003017.pub2]
109. Martin AE, Newlove-Delgado TV, Abbott RA, Bethel A, Thompson-Coon J, Nikolaou V, et al. Pharmacological interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD010973]